Marothi, Y. A.; Agnihotri, H.; Dubey, D.
October 2005
Indian Journal of Medical Microbiology;Oct2005, Vol. 23 Issue 4, p214
Academic Journal
Nosocomial acquisition of microorganisms resistant to multiple antibiotics represents a threat to patient safety. Here, we review the antimicrobial resistance in Enterococcus, which makes it important nosocomial pathogen. The emergence of enterococci with acquired resistance to vancomycin has been particularly problematic as it often occurs in enterococci that are also highly resistant to ampicillin and aminoglycoside thereby associated with devastating therapeutic consequences. Multiple factors contribute to colonization and infection with vancomycin resistant enterococci ultimately leading to environmental contamination and cross infection. Decreasing the prevalence of these resistant strains by multiple control efforts therefore, is of paramount importance.


Related Articles

  • Insight into antimicrobial susceptibility and population structure of contemporary human Enterococcus faecalis isolates from Europe. Kuch, Alicja; Willems, Rob J. L.; Werner, Guido; Coque, Teresa M.; Hammerum, Anette M.; Sundsfjord, Arnfinn; Klare, Ingo; Ruiz-Garbajosa, Patricia; Simonsen, Gunnar S.; van Luit-Asbroek, Miranda; Hryniewicz, Waleria; Sadowy, Ewa // Journal of Antimicrobial Chemotherapy (JAC);Mar2012, Vol. 67 Issue 3, p551 

    Objectives To investigate antimicrobial susceptibility and clonal relatedness of Enterococcus faecalis human isolates recovered recently (2006–09) in six European countries. Methods Antimicrobial susceptibility of 386 isolates from Denmark, Germany, Norway, Poland, Spain and The...

  • Discovery of Medically Significant Lantibiotics. Piper, Clare; Cotter, Paul D.; Ross, R. Paul; Hill, Colin // Current Drug Discovery Technologies;Mar2009, Vol. 6 Issue 1, p1 

    The emergence of drug-resistant pathogens such as staphylococci and enterococci in the hospital setting has long being recognized as a serious clinical problem. Staphylococcus aureus is the causative agent of many nosocomial infections from minor skin abscesses to serious, potentially life...

  • Vancomycin-Resistant Enterococci: Colonization, Infection, Detection, and Treatment. Zirakzadeh, Ali; Patel, Robin // Mayo Clinic Proceedings;Apr2006, Vol. 81 Issue 4, p529 

    Vancomycin-resistant enterococci (VRE) are becoming a major concern in medical practice. Their increased prevalence and their ability to transfer vancomycin resistance to other bacteria (including methicillin-resistant Staphylococcus aureus) have made them a subject of close scrutiny and intense...

  • Impact of Vancomycin Resistance on Mortality among Patients with Neutropenia and Enterococcal Bloodstream Infection. DiazGranados, Carlos A.; Jernigan, John A. // Journal of Infectious Diseases;2/15/2005, Vol. 191 Issue 4, p588 

    We performed a retrospective cohort study to measure the impact of vancomycin resistance on clinical outcome for 83 episodes of enterococcal bloodstream infection (BSI; 22 with vancomycin-resistant enterococci [VRE] and 61 with vancomycin-susceptible enterococci [VSE]) in 77 patients with...

  • New Approaches to Develop Anti-Staphylococcal Agents. Lei Pei // Current Medicinal Chemistry - Anti-Infective Agents;Dec2004, Vol. 3 Issue 4, p267 

    Staphylococci are important pathogens of nosocomial infections and foreign body associated infections. Although anti-microbial agents have played important roles in modern medicine and are well developed, antibiotic resistance of microorganisms has increased rapidly, shortening the useful...

  • Multivalent Vancomycins and Related Antibiotics Against Infectious Diseases. Lihua Li; Bing Xu // Current Pharmaceutical Design;Sep2005, Vol. 11 Issue 24, p3111 

    This review discusses the recent development of multivalent antibiotics as potential therapeutic agents against infections caused by antimicrobial drug resistant microbes. The discussion focuses on vancomycin because of its important clinical relevance and well-elucidated molecular mechanism of...

  • Vancomycin-Resistant Staphylococcus aureus: A Real and Present Danger? Hamilton-Miller, J. M. // Infection;Jun2002, Vol. 30 Issue 3, p118 

    The glycopeptide antibiotics, vancomycin and teicoplanin, are the mainstay of therapy for infections involving strains of Staphylococcus aureus that are resistant to methicillin and gentamicin. During the last 5 years, clinical isolates of S. aureus showing reduced susceptibility to...

  • Failure of Daptomycin Monotherapy for Endocarditis Caused by an Enterococcus faecium Strain with Vancomycin-Resistant and Vancomycin-Susceptible Subpopulations and Evidence of In Vivo Loss of the vanA Gene Cluster. Arias, Cesar A.; Torres, Harrys A.; Singh, Kavindra V.; Panesso, Diana; Moore, Judson; Wanger, Audrey; Murray, Barbara E. // Clinical Infectious Diseases;11/15/2007, Vol. 45 Issue 10, p1343 

    A patient with native valve endocarditis caused by a vancomycin ‘heteroresistant’ strain of Enterococcus faecium experienced failure of daptomycin monotherapy without evidence of daptomycin resistance. The infecting organism exhibited in vivo emergence of a vancomycin-susceptible...

  • Multidrug-resistant Intestinal Staphylococcus aureus among Self-medicated Healthy Adults in Amassoma, South-South, Nigeria. Onanuga, Adebola; Temedie, Tarilate C. // Journal of Health, Population & Nutrition;Oct2011, Vol. 29 Issue 5, p446 

    Multiple antibiotic resistant Staphylococcus aureus is one of the common causes of severe nosocomial infections, and the gastrointestinal tract is an important source of its transmission. This study assessed the previous usage of antibiotics by healthy adults (university students and villagers)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics